A comparative study between intravenous and oral alendronate administration for the treatment of osteoporosis

SpringerPlus

Table 1 Comparisons of baseline variables in intravenous drip and oral prescription group

	Oral prescription group (n = 50)	Intravenous drip group (n = 90)	p value
Age (years)	76 ± 7.9	80 ± 6.4	0.200^a
Height (cm)	153 ± 4.2	150 ± 5.3	0.015^a
Weight (kg)	54.8 ± 8.9	50.2 ± 7.6	0.023^a
BMI (kg/m²)	25 ± 4.0	24.1 ± 3.6	0.201^a
BMD: femur (g/cm²)	0.464 ± 0.035	0.491 ± 0.052	0.538^a
BMD: lumbar spine (g/cm²)	0.585 ± 0.042	0.552 ± 0.028	0.052^a
Previous fracture (n)	5	10	0.158^b
Incidence ratio of fracture (n)	0	2	0.205^b
Adverse drug reactions (n)	2	0	0.204^b